|[December 03, 2013]
Research and Markets: Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/k8m637/global)
has announced the addition of the "Global
Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities
(2013-2018)" report to their offering.
The report titled 'Global Age-Related Macular Degeneration (AMD (News - Alert)) Market:
Trends & Opportunities (2013-2018)' provides an in-depth analysis of the
global age-related macular degeneration market with detailed analysis of
various countries like the United States, U.K., and Australia.
The report assesses the key opportunities in the market and outlines the
factors that are and will be driving the growth of the industry. Growth
of the overall AMD market has also been forecasted for the period
2013-2018, taking into consideration the previous growth patterns, the
growth drivers and the current and future trends. Further, key players
of the industry lie Novartis, Regeneron, Roche and Bayer are profiled.
Age-related macular degeneration (AMD) is a condition affecting older
people, and involves the loss of the person's central field of vision.
Several forms of AMD exist such as early AMD, late AMD, dry AMD, Wet
AMD, etc. Globally, the disease ranks third as a cause of blindness
after cataract and glaucoma. The main factor is aging and other risk
factors may include the use of tobacco, genetic tendencies, the degree
of pigmentation (with light-colored eyes being at higher risk), arterial
hypertension, the ultraviolet rays, and consumption of a non-balanced
diet. As for the cure of the disease, there is at present no definitive
treatment. Palliative treatments which are able to retard the progress
of the disease include the use of intravitreous drugs or injections,
lasers, dynamic phototherapy and sometimes surgery.
Globally the prevalence of AMD disease is highest in the U.S. followed
by the U.K. and Australia. The world's elderly population is the fastest
growing age group; this is the main reason for the rising prevalence of
AMD. Rising smoking habits and unhealthy diet are the other reasons
which will increase the count of AMD affected people in the near future.
New types of drugs such as Eylea have come up which is indicated for the
treatment of patients with neovascular (wet) age-related macular
degeneration and expected to substitute Lucentis and Avastin drugs in
the coming years.
For more information visit http://www.researchandmarkets.com/research/k8m637/global
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ InfoTech Spotlight's Homepage ]